drugset / Trial / NCT06286033
Single and Multiple Ascending Dose Study and Food Effect Study for AG181
RandomizedSequentialQuadruple-blindTreatment
Summary
The primary purpose of this study is to assess the safety and tolerability of AG-181 in healthy participants after oral administration of single ascending dose (SAD) of AG-181 in Part 1 and multiple ascending dose (MAD) in Part 2 along with the effect of food on the pharmacokinetics (PK) of single oral doses of AG-181 in healthy participants in Part 3.
Timeline
- Start
- 2024-02-20
- Primary completion
- 2025-10-09
- Completion
- 2025-10-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AG-181 | Unknown | — | Oral |
Indications
No indication recorded.